Literature DB >> 15571829

Myocardial bridging is associated with alteration in coronary vasoreactivity.

Joerg Herrmann1, Stuart T Higano, Ryan J Lenon, Charanjit S Rihal, Amir Lerman.   

Abstract

BACKGROUND: Shear stress alteration has been recognized as a predisposing factor for the impairment of endothelial function. Myocardial bridging is a congenital condition associated with alteration in shear stress, however, its impact upon vasoreactivity remains undetermined. METHODS AND
RESULTS: This was a case-control designed study with 29 patients with myocardial bridging and 58 patients without myocardial bridging. Endothelium-dependent and endothelium-independent changes in coronary artery diameters, blood flow and wall shear stress were determined after intracoronary infusion of acetylcholine (ACH, 10(-6)-10(-4) mol/L) and nitroglycerine (NTG, 200 microg). Coronary flow velocity reserve (CFVR) was determined after intracoronary injection of adenosine (18-36 microg). In response to ACH, there was more epicardial vasoconstriction at the myocardial bridging site compared with the proximal and distal segments (-29.6+/-21.7 vs. -9.6+/-22.5 and -17.4+/-21.5%, p<0.05) and compared with the control group (-29.6+/-21.7 vs. -5.9+/-36.5%, p<0.001). The response to NTG and CFVR was the same in the case and the control group. Wall shear rate (WSR) was higher in the MB site at baseline and in response to ACH.
CONCLUSIONS: MB is characterised by enhanced WSR and impairment in endothelium-dependent vasorelaxation. These functional alterations may add to the severity of structural lumen compression and thus to the clinical presentation of this congenital abnormality.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15571829     DOI: 10.1016/j.ehj.2004.08.015

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  23 in total

1.  Bridging and spasming.

Authors:  Joerg Herrmann; David R Holmes
Journal:  Tex Heart Inst J       Date:  2012

Review 2.  Multimodality Imaging in the Assessment of the Physiological Significance of Myocardial Bridging.

Authors:  Valtteri Uusitalo; Antti Saraste; Juhani Knuuti
Journal:  Curr Cardiol Rep       Date:  2016-01       Impact factor: 2.931

3.  SPECT perfusion imaging and myocardial bridges: bridging the gap of diagnostic uncertainty.

Authors:  Erin M Galbraith; Parham Eshtehardi; Habib Samady
Journal:  J Nucl Cardiol       Date:  2011-12       Impact factor: 5.952

Review 4.  Cardiac syndrome X and microvascular coronary dysfunction.

Authors:  Erika Jones; Wafia Eteiba; Noel Bairey Merz
Journal:  Trends Cardiovasc Med       Date:  2012-09-29       Impact factor: 6.677

5.  Myocardial bridging with left ventricular hypertrophy presenting as Wellens pattern.

Authors:  Ahmad Abuarqoub; Maria Naranjo; Fayez Shamoon
Journal:  Ann Transl Med       Date:  2017-10

6.  Differential local spasticity in myocardial bridges.

Authors:  Paolo Angelini; Carlo Uribe; Pablo Lozano
Journal:  Tex Heart Inst J       Date:  2012

7.  Prevalence and predictors of bridging of coronary arteries in a large Indonesian population, as detected by 64-slice computed tomography scan.

Authors:  J Wirianta; M Mouden; J P Ottervanger; J R Timmer; Y B Juwana; M-J de Boer; H Suryapranata
Journal:  Neth Heart J       Date:  2012-10       Impact factor: 2.380

Review 8.  Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies.

Authors:  Michel T Corban; Olivia Y Hung; Parham Eshtehardi; Emad Rasoul-Arzrumly; Michael McDaniel; Girum Mekonnen; Lucas H Timmins; Jerre Lutz; Robert A Guyton; Habib Samady
Journal:  J Am Coll Cardiol       Date:  2014-02-26       Impact factor: 24.094

9.  Tunneled left anterior descending artery in a child with hypertrophic cardiomyopathy.

Authors:  Iacopo Olivotto; Franco Cecchi; Roberta Bini; Silvia Favilli; Bruno Murzi; Ismail El-Hamamsy; Magdi H Yacoub
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2008-12-17

10.  Myocardial bridges spared from atherosclerosis: overview of the underlying mechanisms.

Authors:  Yiannis S Chatzizisis; George D Giannoglou
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.